ODT

Odonate Therapeutics (ODT)

Odonate Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ODT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/02/11	02 : 31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/02/07	23 : 01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/31	20 : 14	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/31	20 : 14	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/31	20 : 11	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	23 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	23 : 01	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	23 : 00	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	23 : 00	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	23 : 00	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/26	07 : 31	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/07	23 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ODT	Odonate Therapeutics Inc
2022/01/07	23 : 00	Business Wire	Odonate Announces Expected Delisting of Its Stock	NASDAQ:ODT	Odonate Therapeutics Inc
2021/12/11	08 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/12/11	07 : 24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/25	08 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/23	01 : 09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/20	07 : 08	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/19	07 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/19	03 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/17	21 : 45	Business Wire	Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/11	07 : 15	Business Wire	Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021	NASDAQ:ODT	Odonate Therapeutics Inc
2021/11/11	07 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/09/08	20 : 00	GlobeNewswire Inc.	SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm	NASDAQ:ODT	Odonate Therapeutics Inc
2021/08/06	05 : 35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/07/27	21 : 30	Business Wire	Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021	NASDAQ:ODT	Odonate Therapeutics Inc
2021/07/27	21 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/07/03	05 : 07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/06/26	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ODT	Odonate Therapeutics Inc
2021/06/02	05 : 31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ODT	Odonate Therapeutics Inc